SCHEMBL247642

SCHEMBL247642

Nc1cc(N2CCOCC2)ncc1C1=CCSC(O)C1O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 13/20 0.38
MTOR P42345 8/20 0.38
CNR2 P34972 2/20 0.35
KMO O15229 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP1A2 P05177 1/20 0.34
MAPT P10636 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
PIK3CB P42338 2/20 0.33
ADK P55263 1/20 0.33
PIK3CD O00329 1/20 0.33
PIK3C2B O00750 1/20 0.33
PIK3R1 P27986 1/20 0.33
AKR1C3 P42330 1/20 0.33
PIK3CG P48736 1/20 0.33
PRKDC P78527 1/20 0.33
PIK3C3 Q8NEB9 1/20 0.33
PIK3R5 Q8WYR1 1/20 0.33
PI4KB Q9UBF8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL247784 0.71 PIK3CA (0.38) PIK3CAMTORCNR2ALDH1A1CYP1A2
SCHEMBL15543262 0.70 ALDH1A1 (0.48) PIK3CAMTORCNR2KMOALDH1A1
SCHEMBL29745217 0.70 ALDH1A1 (0.48) PIK3CAMTORCNR2KMOALDH1A1
SCHEMBL247209 0.69 LRRK2 (0.43) PIK3CAMTORCNR2KMOCYP2C19
SCHEMBL246131 0.67 CYP2C19 (0.59) PIK3CAMTORALDH1A1CYP1A2MAPT
SCHEMBL14840567 0.67 PIK3CA (0.39) PIK3CAMTORCNR2KMOALDH1A1
SCHEMBL246534 0.66 ALDH1A1 (0.44) PIK3CAMTORCNR2KMOALDH1A1
SCHEMBL14910307 0.66 KDM4E (0.47) PIK3CAMTORCNR2KMOALDH1A1
SCHEMBL21246773 0.66 CNR2 (0.52) PIK3CACNR2ALDH1A1CYP1A2MAPT
SCHEMBL245708 0.66 PIK3CA (0.47) PIK3CAMTORCNR2KMOALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2588471-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS INHIBITORS OF PI3K ACTIVITY Amgen Inc. (US) 2013-05-08 EP disclosed
WO-2012003283-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS INHIBITORS OF PI3K ACTIVITY AMGEN INC. (US) 2012-01-05 WO disclosed